Study protocol: a multicentre, prospective, phase II trial of isotoxic hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer

por Liu, Yue-E, Xue, Xiao-Ying, Zhang, Rui, Chen, Xue-Ji, Ding, Yu-Xia, Liu, Chao-Xing, Qin, Yue-Liang, Li, Wei-Qian, Ren, Xiao-Cang, Lin, Qiang
Publicado 2020